rs746320191
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP3BS2
The NM_003079.5(SMARCE1):c.369G>A(p.Lys123Lys) variant causes a splice region, synonymous change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000103 in 1,458,872 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003079.5 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCE1 | NM_003079.5 | c.369G>A | p.Lys123Lys | splice_region_variant, synonymous_variant | 6/11 | ENST00000348513.12 | NP_003070.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCE1 | ENST00000348513.12 | c.369G>A | p.Lys123Lys | splice_region_variant, synonymous_variant | 6/11 | 1 | NM_003079.5 | ENSP00000323967.6 | ||
ENSG00000264058 | ENST00000476049.1 | n.*717G>A | splice_region_variant, non_coding_transcript_exon_variant | 8/13 | 5 | ENSP00000463483.1 | ||||
ENSG00000264058 | ENST00000476049.1 | n.*717G>A | 3_prime_UTR_variant | 8/13 | 5 | ENSP00000463483.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250926Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135602
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1458872Hom.: 0 Cov.: 30 AF XY: 0.0000110 AC XY: 8AN XY: 725798
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial meningioma Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Dec 17, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 27, 2023 | This variant has not been reported in the literature in individuals affected with SMARCE1-related conditions. This variant is present in population databases (rs746320191, gnomAD 0.02%). This sequence change affects codon 123 of the SMARCE1 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the SMARCE1 protein. This variant also falls at the last nucleotide of exon 6, which is part of the consensus splice site for this exon. ClinVar contains an entry for this variant (Variation ID: 532241). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). RNA analysis performed to evaluate the impact of this variant on mRNA splicing indicates it does not significantly alter splicing (Invitae). - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jul 28, 2022 | In silico analysis supports a deleterious effect on splicing; Has not been previously published as pathogenic or benign to our knowledge - |
Hereditary cancer-predisposing syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 15, 2020 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at